Has Leslie Hinds, NP received payments from drug or device companies?

Yes. Drug and device makers reported $8,520 in general payments to Leslie Hinds, NP across 333 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leslie Hinds, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leslie Hinds, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leslie Hinds, NP

Nurse Practitioner · Denver, CONPI 1649310244

Payments from drug & device makers

$8,520in general payments, 2019–2025

Across 333 payments — averaging $25.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$815
Novartis$747
Seagen Inc.$566
AstraZeneca$487
Pfizer$443
Daiichi Sankyo Inc.$367
plus $5K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	27	$815
Novartis	18	$747
Seagen Inc.	14	$566
AstraZeneca(2 entities)	24	$487
Pfizer	25	$443
Daiichi Sankyo Inc.	19	$367
Gilead	14	$325
Merck	15	$311
AVEO Pharmaceuticals, Inc.	6	$310
Bristol Myers Squibb	13	$303
E.r. Squibb & Sons, L.L.C.	13	$292
Sanofi	10	$288
Pharmacyclics LLC, An Abbvie Company	8	$269
Genentech USA, Inc.	14	$266
GSK	10	$226
Lilly USA, LLC	5	$215
Karyopharm Therapeutics Inc.	8	$212
EMD Serono, Inc.	6	$174
Beigene USA, Inc.	2	$142
Exelixis Inc.	5	$113
Tersera Therapeutics LLC	5	$109
Amgen	5	$107
Genmab U.S., Inc.	4	$103
Regeneron Healthcare Solutions, Inc.	4	$95
Astellas Pharma US Inc	3	$78
Sobi, Inc	3	$69
Telix Pharmaceuticals	2	$68
Eisai Inc.	3	$65
Pharmacosmos Therapeutics Inc.	3	$62
Ipsen Biopharmaceuticals, Inc	3	$60
Alnylam Pharmaceuticals Inc.	2	$52
Recordati_rare_diseases_inc.	2	$47
Taiho Oncology, Inc.	3	$46
Boston Scientific	1	$44
Coherus Oncology, Inc.	2	$44
Immunocore Limited	2	$39
Sun Pharmaceutical Industries Inc.	2	$37
Stemline Therapeutics Inc.	2	$36
Incyte Corporation	2	$34
Blueprint Medicines Corporation	1	$33
Pharmaessentia USA Corporation	2	$31
Boehringer Ingelheim	2	$31
Morphosys, US Inc.	2	$31
Takeda Pharmaceuticals U.S.A., Inc.	1	$29
Novocure Inc.	1	$28
Dendreon Pharmaceuticals LLC	1	$24
AbbVie	1	$23
Array Biopharma Inc	1	$23
Deciphera Pharmaceuticals Inc.	1	$22
Epizyme, Inc.	1	$20
G1 Therapeutics, Inc.	1	$19
Servier Pharmaceuticals LLC	1	$18
Dova Pharmaceuticals	1	$18
Organon	1	$17
Rigel Pharmaceuticals, Inc.	1	$16
ADC Therapeutics America, Inc.	1	$16
Myovant Sciences Inc.	1	$16
Medtronic	1	$14
Beone Medicines USA, Inc.	1	$14
Myriad Genetic Laboratories, Inc.	1	$14

How this compares

$8,520 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado →

Medicare billing

Part B allowed, 2024

$14,659

Medicare patients

140

Services billed

203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Denver

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →